Skip to content

Menarini inaugurates new regional headquarters in Dubai, UAE

By asianet

The pharmaceutical group, present in 140 countries in the world, aims to raise standard of patient healthcare across the Middle East and Africa (MEA) region with innovative products and breakthrough research Menarini, the leading Italian pharmaceutical group founded in 1886, today opened its regional headquarters in Dubai Science Park as part of its goal to … Continued

Pierre Fabre and EORTC open a large Phase III clinical study in the adjuvant setting of stage IIB-C melanoma

By asianet

– First study conducted in the adjuvant setting with a combination of BRAF and MEK inhibitors in high-risk stage II BRAF V600E/K-mutant cutaneous melanoma – A global partnership between EORTC and Pierre Fabre to advance research in melanoma Pierre Fabre and the European Organisation for Research and Treatment of Cancer (EORTC) today announced the screening … Continued

Insilico Medicine Announces Novel 3CL Protease Inhibitor Preclinical Candidate for COVID-19 Treatment

By asianet

-Insilico’s candidate demonstrated a favorable profile with good in vivo efficacy at low doses, efficient synthesis, and no need for co-administration with Ritonavir. -The candidate is intended to be used for the treatment of SARS-CoV-2 and its variants, along with other coronaviruses. -Insilico’s candidate has a novel structure that can be synthesized efficiently, designed by … Continued

UAE powerhouse VPS Healthcare launches Burjeel Holdings to scale the next generation of its growth

By asianet

On the sidelines of the World Economic Forum Annual Meeting, the UAE-based private healthcare services platform commits 50 pediatric stem cell transplantations to refugees of the Ukraine conflict The UAE-based VPS Healthcare has announced the launch of Burjeel Holdings on the sidelines of the World Economic Forum Annual Meeting in Davos on Sunday to consolidate … Continued

Fullerton Health Chronicles COVID-19 Journey in E-book

By asianet

Fullerton Health has today released ‘The Mighty Storm – Fullerton Health Rises to the Challenge’, a 68-page e-book that chronicles Fullerton Health’s struggles, challenges and successes in support of the nation’s two-year fight against the pandemic. The e-book tells the Fullerton Health COVID-19 story from the perspectives of Fullerton Health’s doctors, nurses, corporate employees and … Continued

OptraSCAN’s Artificial Intelligence-Equipped Digital Pathology Scanner OS-SiA Granted U.S Patent for Scanning, Indexing and Analyzing of the Tissue Area at the Same Time

By asianet

OptraSCAN(R) [https://www.optrascan.com/], the leading end-to-end digital pathology solution provider, announced its digital pathology scanner OS-SiA has been granted US patent – No 2020/0334814 A1 by the United States Patent and Trademark Office. OS-SiA has inbuilt intelligence to scan, index and analyze pathological samples simultaneously. This will benefit the end-user to view the whole slide scanned … Continued

Medison Pharma Announces Extension of Multi-territorial Agreement with Immunocore and Expansion into Australia and New Zealand

By asianet

Medison Pharma [https://www.medisonpharma.com/] (“Medison”), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, today announced the addition of new markets to its multi-territorial agreement with Immunocore Holdings plc [https://www.immunocore.com/] (Nasdaq: IMCR) (“Immunocore”), a commercial-stage biotechnology company pioneering the development of a novel class of T cell receptor … Continued

Karyopharm and Menarini Group Receive Positive CHMP Opinion for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Refractory Multiple Myeloma

By asianet

— European Commission Decision Anticipated within Approximately 60 Days — Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, leading international pharmaceutical company, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion … Continued

Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology

By asianet

-Emerald study met both its primary end points of Progression-free survival (PFS) in overall population and in ESR1 mutated patients -PFS rate at 12 months with elacestrant was 22.32% vs. 9.42% with SOC in the overall population, and 26.76% vs. 8.19% in the ESR1 mutation population -Data demonstrated elacestrant significantly reduced the risk of disease … Continued

Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super Specialty Center partner with Darwinbox to achieve total Digital Transformation

By asianet

Labaid Ltd. (Diagnostics) and Labaid Cancer Hospital & Super Specialty Center, a part of the Labaid Group, have partnered with Darwinbox to achieve total digital transformation by 2026. This is in line with their vision of becoming Bangladesh’s ‘trusted healthcare provider’ and aggressive business growth. Darwinbox’s addition is specifically to supercharge the HR operations and … Continued